Inventor · disambiguated record
Nicholas Simon Stock
Also filed as: STOCK NICHOLAS · STOCK NICHOLAS S · STOCK NICHOLAS SIMON
36 granted patents·17 pending applications·274 citations·filing 2004–2025
97Inventor score
Files withAMIRA PHARMACEUTICALS INC10PANMIRA PHARMACEUTICALS LLC7NOVIRA THERAPEUTICS INC6HUTCHINSON JOHN H5TEMPEST THERAPEUTICS INC5
Top patents by PatentIndex Score
53 records- 0196US7405302B25-lipoxygenase-activating protein (FLAP) inhibitorsAMIRA PHARMACEUTICALS INC·Filed 2006·Granted Jul 29, 2008·105 cites·5 claims
- 0291US8067445B2N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptorsHUTCHINSON JOHN HOWARD·Filed 2009·Granted Nov 29, 2011·14 cites·31 claims
- 0389US9000025B2Autotaxin inhibitors and uses thereofROPPE JEFFREY ROGER·Filed 2011·Granted Apr 7, 2015·17 cites·20 claims
- 0489US8664220B2Polycyclic compounds as lysophosphatidic acid receptor antagonistsCLARK RYAN·Filed 2010·Granted Mar 4, 2014·17 cites·4 claims
- 0589US8362044B2N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptorsPANMIRA PHARMACEUTICALS LLC·Filed 2011·Granted Jan 29, 2013·11 cites·21 claims
- 0689US8217066B2Compounds as lysophosphatidic acid receptor antagonistsSEIDERS THOMAS JON·Filed 2010·Granted Jul 10, 2012·14 cites·16 claims
- 0789US7834037B25-lipoxygenase-activating protein (FLAP) inhibitorsAMIRA PHARMACEUTICALS INC·Filed 2007·Granted Nov 16, 2010·11 cites·19 claims
- 0888US7977359B25-lipdxygenase-activating protein (FLAP) inhibitorsAMIRA PHARMACEUTICALS INC·Filed 2006·Granted Jul 12, 2011·11 cites·12 claims
- 0988US7795274B25-lipoxygenase-activating protein (FLAP) inhibitorsAMIRA PHARMACEUTICALS INC·Filed 2008·Granted Sep 14, 2010·11 cites·4 claims
- 1083US8399666B25-lipoxygenase-activating protein (FLAP) inhibitorsHUTCHINSON JOHN H·Filed 2006·Granted Mar 19, 2013·10 cites·5 claims
- 1182US10160742B2Pyridyl reverse sulfonamides for HBV treatmentNOVIRA THERAPEUTICS INC·Filed 2017·Granted Dec 25, 2018·1 cites·8 claims
- 1282US9272990B2Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosisSEIDERS THOMAS JON·Filed 2011·Granted Mar 1, 2016·8 cites·7 claims
- 1382US8383654B2Heterocyclic antagonists of prostaglandin D2 receptorsPANMIRA PHARMACEUTICALS LLC·Filed 2009·Granted Feb 26, 2013·6 cites·18 claims
- 1482US8378107B2Heteroaryl antagonists of prostaglandin D2 receptorsPANMIRA PHARMACEUTICALS LLC·Filed 2009·Granted Feb 19, 2013·6 cites·19 claims
- 1579US2024041837A1Triazolone compounds and uses thereofTEMPEST THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1677US9849109B2Autotaxin inhibitors and uses thereofAMIRA PHARMACEUTICALS INC·Filed 2015·Granted Dec 26, 2017·2 cites·8 claims
- 1777US9597332B2Sulfide alkyl compounds for HBV treatmentNOVIRA THERAPEUTICS INC·Filed 2015·Granted Mar 21, 2017·1 cites·9 claims
- 1877US9090573B2Compounds as lysophosphatidic acid receptor antagonistsSEIDERS THOMAS J·Filed 2010·Granted Jul 28, 2015·6 cites·4 claims
- 1977US8049015B2Heteroaryl antagonists of prostaglandin D2 receptorsPANMIRA PHARMACEUTICALS LLC·Filed 2009·Granted Nov 1, 2011·3 cites·36 claims
- 2076US10196351B2Sulfide alkyl compounds for HBV treatmentNOVIRA THERAPEUTICS INC·Filed 2017·Granted Feb 5, 2019·1 cites·19 claims
- 2174US10568871B2Triazolone compounds and uses thereofTEMPEST THERAPEUTICS INC·Filed 2017·Granted Feb 25, 2020·1 cites·20 claims
- 2274US9676754B2Triazolone compounds and uses thereofINCEPTION 2 INC·Filed 2013·Granted Jun 13, 2017·2 cites·18 claims
- 2373US9765050B2Pyridyl reverse sulfonamides for HBV treatmentNOVIRA THERAPEUTICS INC·Filed 2015·Granted Sep 19, 2017·1 cites·9 claims
- 2472US8785393B2Ophthalmic pharmaceutical compositions of DP2 receptor antagonistsHUTCHINSON JOHN HOWARD·Filed 2010·Granted Jul 22, 2014·2 cites·22 claims
- 2572US7332516B2Geminally di-substituted NSAID derivatives as Aβ42 lowering agentsMERCK & CO INC·Filed 2004·Granted Feb 19, 2008·6 cites·7 claims
- 2671US9776976B2Triazolone compounds and uses thereofINCEPTION 2 INC·Filed 2014·Granted Oct 3, 2017·2 cites·23 claims
- 2771US8841295B25-lipoxygenase-activating protein (FLAP) inhibitorsHUTCHINSON JOHN H·Filed 2006·Granted Sep 23, 2014·1 cites·16 claims
- 2870US10710959B2Sulfide alkyl compounds for HBV treatmentNOVIRA THERAPEUTICS INC·Filed 2018·Granted Jul 14, 2020·0 cites·8 claims
- 2970US9624182B2Compounds as lysophosphatidic acid receptor antagonistsAMIRA PHARMACEUTICALS INC·Filed 2015·Granted Apr 18, 2017·1 cites·13 claims
- 3069US11666557B2Triazolone compounds and uses thereofTEMPEST THERAPEUTICS INC·Filed 2019·Granted Jun 6, 2023·0 cites·19 claims
- 3169US9505728B2Triazolone compounds and uses thereofINCEPTION 2 INC·Filed 2013·Granted Nov 29, 2016·2 cites·25 claims
- 3266US10428041B2Pyridyl reverse sulfonamides for HBV treatmentNOVIRA THERAPEUTICS INC·Filed 2018·Granted Oct 1, 2019·0 cites·20 claims
- 3364US8697730B25-lipoxygenase activating protein (FLAP) inhibitorREWOLINSKI MELISSA VIRGINIA·Filed 2008·Granted Apr 15, 2014·1 cites·15 claims
- 3459US8710081B25-lipoxygenase-activating protein (FLAP) inhibitorsPANMIRA PHARMACEUTICALS LLC·Filed 2013·Granted Apr 29, 2014·0 cites·15 claims
- 3559US2013158036A1N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptorsPANMIRA PHARMACEUTICALS LLC·Filed 2012·Application pending·0 cites
- 3655US2025313548A1Heterocyclic compounds useful as kcnt1 inhibitorsACTIO BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 3754US2012027842A1Topical formulations of flap inhibitors for administration to an eyeHUTCHINSON JOHN HOWARD·Filed 2009·Application pending·0 cites
- 3851US2011098352A1N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptorsAMIRA PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 3950US2010298343A15-lipoxygenase-activating protein (flap) inhibitorsHUTCHINSON JOHN HOWARD·Filed 2008·Application pending·0 cites
- 4050US2011034514A15-Lipoxygenase-Activating Protein (FLAP) InhibitorsAMIRA PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 4148US2011118315A15-lipoxygenase-activating protein (flap) inhibitorsHUTCHINSON JOHN H·Filed 2011·Application pending·0 cites
- 4247US2010204282A1Reverse indoles as 5-lipoxygenase-activating protein (FLAP) inhibitorsHUTCHINSON JOHN H·Filed 2008·Application pending·0 cites
- 4347US2018079745A1Pyrazolone compounds and uses thereofTEMPEST THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4445US2010068301A1Compositions and treatments comprising 5-lipoxygenase-activating protein inhibitors and nitric oxide modulatorsHUTCHINSON JOHN H·Filed 2007·Application pending·0 cites
- 4545US2007219206A15-lipoxygenase-activating protein (flap) inhibitorsAMIRA PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 4644US2007225285A15-lipoxygenase-activating protein (flap) inhibitorsAMIRA PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 4744US2007099950A1Pyridin-4-ylamine compounds useful in the treatment of neuropathic painLIM JONGWON·Filed 2004·Application pending·0 cites
- 4842US8772495B25-lipoxygenase-activating protein inhibitorSCHAAB KEVIN MURRAY·Filed 2009·Granted Jul 8, 2014·0 cites·7 claims
- 4940US9862708B2Pyrazolone compounds and uses thereofTEMPEST THERAPEUTICS INC·Filed 2015·Granted Jan 9, 2018·0 cites·19 claims
- 5040US2007142453A11-Alkyl-3-thio-substituted indole-2-alkynoic acids useful for the treatment of alzheimer's disease and related conditionsBEHER DIRK·Filed 2004·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Nicholas Simon Stock files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →